These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2878816

  • 1. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A, Ahn HS, Billard W, Gold EH, Kohli JD, Glock D, Goldberg LI.
    Eur J Pharmacol; 1986 Sep 09; 128(3):249-53. PubMed ID: 2878816
    [Abstract] [Full Text] [Related]

  • 2. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 3. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 02; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
    Kostrzewa RM, Saleh MI.
    Neuropharmacology; 1989 Aug 02; 28(8):805-10. PubMed ID: 2571103
    [Abstract] [Full Text] [Related]

  • 5. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC, Bennett JP.
    Brain Res Dev Brain Res; 1990 Mar 01; 52(1-2):273-7. PubMed ID: 2110042
    [Abstract] [Full Text] [Related]

  • 6. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.
    Hyttel J.
    Neuropharmacology; 1984 Dec 01; 23(12A):1395-401. PubMed ID: 6152023
    [Abstract] [Full Text] [Related]

  • 7. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
    Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA.
    J Pharmacol Exp Ther; 1983 Aug 01; 226(2):462-8. PubMed ID: 6135795
    [Abstract] [Full Text] [Related]

  • 8. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH, Braestrup C.
    J Neurochem; 1986 Dec 01; 47(6):1822-31. PubMed ID: 2945903
    [Abstract] [Full Text] [Related]

  • 9. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 10. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D, Trovero F, Blanc G, Glowinski J, Tassin JP.
    Neuroscience; 1992 Jul 07; 46(3):687-700. PubMed ID: 1532052
    [Abstract] [Full Text] [Related]

  • 11. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Oct 30; 106(1):219-20. PubMed ID: 6241567
    [No Abstract] [Full Text] [Related]

  • 12. [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.
    Sidhu A, van Oene JC, Dandridge P, Kaiser C, Kebabian JW.
    Eur J Pharmacol; 1986 Sep 09; 128(3):213-20. PubMed ID: 2947806
    [Abstract] [Full Text] [Related]

  • 13. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1985 Sep 24; 115(2-3):291-5. PubMed ID: 2866103
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
    Andersen PH, Jansen JA.
    Eur J Pharmacol; 1990 Jun 12; 188(6):335-47. PubMed ID: 1973652
    [Abstract] [Full Text] [Related]

  • 15. DA1 dopamine receptors in renal cortical collecting duct.
    Ohbu K, Felder RA.
    Am J Physiol; 1991 Nov 12; 261(5 Pt 2):F890-5. PubMed ID: 1683170
    [Abstract] [Full Text] [Related]

  • 16. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
    Neumeyer JL, Kula NS, Baldessarini RJ, Baindur N.
    J Med Chem; 1992 Apr 17; 35(8):1466-71. PubMed ID: 1533424
    [Abstract] [Full Text] [Related]

  • 17. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ, Chen LJ, Jin GZ, Creese I.
    Biochem Pharmacol; 1997 Jul 15; 54(2):227-32. PubMed ID: 9271326
    [Abstract] [Full Text] [Related]

  • 18. The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390.
    Itoh Y, Beaulieu M, Kebabian JW.
    Eur J Pharmacol; 1984 Apr 13; 100(1):119-22. PubMed ID: 6144550
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
    Claudi F, Cingolani GM, Giorgioni G, Cattabeni F, Cimino M, Di Luca M.
    Drug Des Deliv; 1989 Jun 13; 4(4):279-87. PubMed ID: 2570592
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
    Berger JG, Chang WK, Clader JW, Hou D, Chipkin RE, McPhail AT.
    J Med Chem; 1989 Aug 13; 32(8):1913-21. PubMed ID: 2666667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.